On Friday, FDA announced that it had delayed its decision to approve a $20-billion rescue package for millions of Americans in the aftermath of Hurricane Matthew.
The package would allow Americans to stay in their homes until the storm clears.
The agency’s decision came as a result of concerns over safety in the first-ever emergency declaration that could result from a storm surge.
But the agency also said it would be reviewing the package for other factors, such as whether it meets other standards for relief.
“Given the importance of our nation to the state of Florida, Florida’s Governor, and the residents of Florida and the Gulf Coast, we will be assessing the emergency declaration process in light of other factors,” the FDA said in a statement.
On Tuesday, the agency will be holding a special meeting to discuss the package, and FDA will be asking the public to provide feedback.
The Hurricane Matthew relief package has been in the works for more than a year, with FDA first announcing it in April.
The hurricane made landfall in the Gulf of Mexico on October 30, destroying homes and flooding streets.
The Federal Emergency Management Agency, FEMA, was among the first agencies to offer relief and evacuation assistance for residents in need, including those in Florida and Florida Keys.
“The state and local governments are working hard to provide the most effective relief and emergency response, and we appreciate their efforts and support,” FEMA Director Brock Long said in the statement.
“However, in this storm, it is critical that all stakeholders have the ability to access the critical services they need.”